SCOR (SCR) Aktienübersicht
SCOR SE bietet zusammen mit ihren Tochtergesellschaften Lebens- und Nichtlebensrückversicherungsprodukte in Europa, dem Nahen Osten, Afrika, Nord- und Südamerika, Lateinamerika und im asiatisch-pazifischen Raum an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 0/6 |
| Vergangene Leistung | 5/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 5/6 |
Belohnungen
Risikoanalyse
SCR Community Fair Values
Create NarrativeSee what 36 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
SCOR SE Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | €31.88 |
| 52-Wochen-Hoch | €33.48 |
| 52-Wochen-Tief | €25.30 |
| Beta | 0.52 |
| 1 Monat Veränderung | 4.18% |
| 3 Monate Veränderung | -0.75% |
| 1 Jahr Veränderung | 11.00% |
| 3 Jahre Veränderung | 17.73% |
| 5 Jahre Veränderung | 27.52% |
| Veränderung seit IPO | -83.73% |
Aktuelle Nachrichten und Updates
SCR: Q1 Resilience And Refined Assumptions Will Shape Future Balance
The SCOR price target has been lifted by a few euros overall, with analysts citing refreshed assumptions around discount rates, profit margins and P/E expectations as key supports for the updated valuation. Analyst Commentary Recent Street research on SCOR points to a cluster of higher price targets, with analysts updating their models around discount rates, profit margins and P/E assumptions.SCR: Higher Payout And Refined Assumptions Will Shape Future Balance
The analyst price target for SCOR has been nudged higher to €33.92 from €33.86, reflecting recent target increases from several firms as analysts factor in updated assumptions on discount rates, profit margins and P/E expectations. Analyst Commentary Recent research updates cluster on the same message, with several firms adjusting their price targets higher and reinforcing an optimistic stance on SCOR’s execution and valuation.SCR: Rising Street Confidence And Dividend Policy Will Shape Future Balance
SCOR's updated analyst price target edges up from €33.00 to about €33.86, reflecting analysts' recent target increases at several banks. These increases point to slightly higher fair value and P/E assumptions, despite more cautious revenue growth inputs.Recent updates
SCR: Q1 Resilience And Refined Assumptions Will Shape Future Balance
The SCOR price target has been lifted by a few euros overall, with analysts citing refreshed assumptions around discount rates, profit margins and P/E expectations as key supports for the updated valuation. Analyst Commentary Recent Street research on SCOR points to a cluster of higher price targets, with analysts updating their models around discount rates, profit margins and P/E assumptions.SCR: Higher Payout And Refined Assumptions Will Shape Future Balance
The analyst price target for SCOR has been nudged higher to €33.92 from €33.86, reflecting recent target increases from several firms as analysts factor in updated assumptions on discount rates, profit margins and P/E expectations. Analyst Commentary Recent research updates cluster on the same message, with several firms adjusting their price targets higher and reinforcing an optimistic stance on SCOR’s execution and valuation.SCR: Rising Street Confidence And Dividend Policy Will Shape Future Balance
SCOR's updated analyst price target edges up from €33.00 to about €33.86, reflecting analysts' recent target increases at several banks. These increases point to slightly higher fair value and P/E assumptions, despite more cautious revenue growth inputs.SCR: Higher Street Expectations And Dividend Plans Will Shape Future Balance
SCOR's updated analyst price target edges higher to about €33, supported by recent Street research that has moved targets into a €34 to €38 range as analysts refine assumptions around discount rate, profit margin and future P/E. Analyst Commentary Recent Street research on SCOR has centered on higher price targets, with several bullish analysts revisiting their assumptions on discount rates, profitability and acceptable P/E levels for the stock.SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Future Balance
The analyst price target for SCOR has been revised slightly higher, with the fair value estimate moving from approximately €32.74 to about €33.01. This adjustment is supported by a series of recent target increases from banks such as Berenberg, Morgan Stanley and Citi, along with an upgrade at BNP Paribas.SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Balanced Outlook
SCOR's updated analyst price target edges higher to €32.74 from €31.98, with analysts citing refreshed models that reflect revised growth and margin assumptions, a modestly higher future P/E multiple, and a series of recent target increases from major banks. Analyst Commentary Recent research updates point to a mixed but generally constructive stance on SCOR, with several price target revisions clustered in the low to mid €30s and one higher target in the high €30s.SCR: Mixed Rating Shifts And New CFO Appointment Shape Balanced Outlook
Analysts have lifted their implied price target on SCOR from about €31.74 to roughly €32, pointing to a slightly higher fair value as they factor in updated growth assumptions and recent target hikes from several banks alongside one downgrade. Analyst Commentary Recent research updates on SCOR reflect a mixed but generally constructive tone, with several firms lifting price targets while one high profile bank has turned more cautious.SCR: Balanced Outlook As Execution And New CFO Transition Guide Rerating Potential
Analysts have nudged their price target on SCOR higher to €32. The modest change reflects a mix of recent target increases, such as Berenberg's €1.50 uplift, and offsetting caution from other firms, all incorporated into updated valuation assumptions.SCR: Execution On Earnings And New CFO Appointment Will Shape Rerating Potential
Analysts have trimmed their price target on SCOR from €32.00 to about €31.74, reflecting slightly lower fair value and profit margin assumptions alongside modestly reduced future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts highlight the recent upgrade to Outperform as a sign that current valuation is seen as reasonable relative to their €32 price target.SCR: Reinsurance Execution And Earnings Quality Will Support Future Rerating
Analysts have inched their average price target for SCOR up to about €32, with small adjustments to discount rate, revenue growth, profit margin and future P/E, reflecting a more finely balanced view after recent rating changes and price target updates across the Street. Analyst Commentary Recent Street research on SCOR has sent mixed signals, with changes in ratings and modest adjustments to price targets clustering around the low €30s.SCR: Reinsurance Pricing And Margin Discipline Will Support Future Rerating
Narrative Update: Analyst Price Targets for SCOR Analysts now see SCOR's price target clustered in the low to mid €30s, with recent updates ranging from about €31.76 to €35 as they adjust their views using broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent target changes for SCOR cluster between about €31.76 and €35.SCR: Rising Reinsurance Pricing And Margin Discipline Will Support Future Upside
The analyst price target for SCOR has edged higher to EUR 31.76 from EUR 31.98, as analysts factor in a slightly lower discount rate, marginally improved profit margin expectations, and supportive upward target revisions from major brokerage houses. Analyst Commentary Recent Street research reflects a generally constructive stance on SCOR, with multiple upward revisions to price targets alongside one modest downgrade.SCR: Rising Reinsurance Pricing And Margin Discipline Will Drive Future Performance
Analysts have nudged their average price target on SCOR slightly lower to about EUR 31.76 from roughly EUR 31.98. This reflects modestly higher discount rate assumptions even as they remain broadly constructive on the shares.SCR: Recent Margin Gains And Improved Outlook Will Drive Future Performance
SCOR's analyst price target has increased modestly from €31.24 to €31.98. Analysts cite slight improvements in profit margin expectations and a supportive outlook from recent Street research as key factors behind the revision.SCR: Improved Margins And Upward Revisions Will Drive Future Share Outperformance
The analyst consensus price target for SCOR fell slightly from €31.998 to €31.244, as analysts cited modestly lower revenue growth projections. This was balanced against improved profit margins and valuation multiples.Analyst Commentary Highlights Rising Confidence in SCOR Amid Upward Revisions and Improved Valuation Metrics
SCOR's analyst price target has increased from €31.36 to €31.99. This change reflects recent analyst confidence in improved profit margins and revenue growth forecasts.Investors Holding Back On SCOR SE (EPA:SCR)
SCOR SE's ( EPA:SCR ) price-to-earnings (or "P/E") ratio of 10.3x might make it look like a buy right now compared to...Elevated Climate Risk And Diversification Will Unlock Reinsurance Value
Analysts have modestly increased their price target for SCOR from $30.81 to $31.36. They cite improved profit margin expectations and a lower discount rate as key factors supporting the upward revision.
Forward 2026 And Decisive P&C Initiatives Poised To Restore Profitability And Boost Earnings
Successful strategic plan and assumption reviews could restore profitability and stabilize future returns through improved business strategies.Aktionärsrenditen
| SCR | FR Insurance | FR Markt | |
|---|---|---|---|
| 7D | 1.9% | 1.3% | -1.8% |
| 1Y | 11.0% | 6.1% | 2.0% |
Rendite im Vergleich zur Industrie: SCR übertraf die Branche French Insurance , die im vergangenen Jahr eine Rendite von 6.1 erzielte.
Rendite vs. Markt: SCR übertraf den Markt French, der im vergangenen Jahr eine Rendite von 2 erzielte.
Preisvolatilität
| SCR volatility | |
|---|---|
| SCR Average Weekly Movement | 3.7% |
| Insurance Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in FR Market | 10.8% |
| 10% least volatile stocks in FR Market | 2.5% |
Stabiler Aktienkurs: SCR hatte in den letzten 3 Monaten im Vergleich zum French -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: SCRDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1956 | 3,610 | Thierry Leger | www.scor.com |
SCOR SE bietet zusammen mit ihren Tochtergesellschaften Lebens- und Nichtlebensrückversicherungsprodukte in Europa, dem Nahen Osten, Afrika, Nord- und Südamerika, Lateinamerika und im asiatisch-pazifischen Raum an. Sie ist in zwei Segmenten tätig, SCOR P&C und SCOR L&H. Das Segment SCOR P&C bietet Rückversicherungsprodukte in den Bereichen Sach-, Motorfahrzeug-, Haftpflicht-, Kredit- und Kautionsversicherungen, Zehnjahresversicherungen, Luftfahrt-, See- und Energieversicherungen, technische Versicherungen, landwirtschaftliche Risiken und Sachkatastrophen; Spezialversicherungen, darunter Business Solutions, politische und Kreditrisiken, Cyber und Umwelthaftpflicht; sowie Business Ventures und Partnerschaften.
SCOR SE's Grundlagenzusammenfassung
| SCR grundlegende Statistiken | |
|---|---|
| Marktanteil | €5.70b |
| Gewinn(TTM) | €876.00m |
| Umsatz(TTM) | €15.48b |
Ist SCR zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| SCR Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | €15.48b |
| Kosten der Einnahmen | €13.72b |
| Bruttogewinn | €1.75b |
| Sonstige Ausgaben | €878.00m |
| Gewinn | €876.00m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
Jul 30, 2026
| Gewinn per Aktie (EPS) | 4.90 |
| Bruttomarge | 11.33% |
| Nettogewinnspanne | 5.66% |
| Schulden/Eigenkapital-Verhältnis | 53.4% |
Wie hat sich SCR auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/10 05:00 |
| Aktienkurs zum Tagesende | 2026/07/10 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
SCOR SE wird von 31 Analysten beobachtet. 11 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Daniel Bischof | Baader Helvea Equity Research |
| Ivan Bokhmat | Barclays |
| Michael Huttner | Berenberg |